BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 25, 2014
View Archived Issues
U.S. DTRA selects Bavarian Nordic's MVA-BN platform for biodefense vaccine development
Read More
Phase III study of volume-reduced subcutaneous C1-INH to prevent HAE attacks begins
Read More
Integrated chemical biology identifies a novel antimalarial drug target
Read More
CHDI Foundation and Genzyme to develop gene-silencing therapeutic for HD
Read More
PDA-001 treatment leads to significant improvements in functional outcome after stroke in rats
Read More
Bionor Pharma reports data from phase I trial of Vacc-C5
Read More
Australian Government funding to benefit Bionomics program
Read More
Novel multitarget agents for pain, inflammation and cancer claimed
Read More
FDA accepts Eylea supplemental BLA for review
Read More
Valneva begins fourth antibody discovery program for Sanofi Pasteur
Read More
Phenex Pharmaceuticals prepares new nuclear receptor ROR-gamma modulators
Read More
NeuraCeq obtains E.U. approval for PET imaging of beta-amyloid neuritic plaque density
Read More
Delayed administration of perlecan DV improves functional recovery in mice post-stroke
Read More
Sirenas Marine Discovery receives SBIR grant for its HIV small-molecule therapeutic
Read More
Fimasartan shows potential for treating stroke
Read More
Biogen Idec designs new autotaxin and/or S1P receptor modulators
Read More
Ardelyx licenses NaPi-2b phosphate inhibitor program to Sanofi
Read More
European Commission grants orphan drug designation to Soliris for prevention of DGF
Read More
Dual daclatasvir-based regimen granted FDA breakthrough therapy designation
Read More
Glenmark Pharmaceuticals discloses novel ITK inhibitors
Read More
FDA accepts Xiaflex supplemental BLA submission for review
Read More
Celladon enters into option agreement with Servier
Read More
Scientists at Roche and Genentech present novel ITK inhibitors for inflammatory disorders
Read More
Calithera Biosciences begins three phase I trials of CB-839
Read More
FDA awards orphan drug designation to Xoma's gevokizumab for pyoderma gangrenosum
Read More
Auris Medical enrolls first patient in European study of AM-101 in peripheral tinnitus
Read More
GenSpera studies G-202 in new phase II trial for recurrent or progressive glioblastoma
Read More